Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...

Descrición completa

Detalles Bibliográficos
Main Authors: Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko
Formato: Artigo
Idioma:Russian
Publicado: «REMEDIUM GROUP» Ltd. 2023-01-01
Series:Атеротромбоз
Subjects:
Acceso en liña:https://www.aterotromboz.ru/jour/article/view/287